Cas no 876716-46-0 (3-cyclohexyl-1,2-oxazole-5-carboxylic acid)
3-cyclohexyl-1,2-oxazole-5-carboxylic acid Chemical and Physical Properties
Names and Identifiers
-
- 3-Cyclohexylisoxazole-5-carboxylic acid
- 3-cyclohexyl-1,2-oxazole-5-carboxylic acid
- 3-Cyclohexyl-isoxazole-5-carboxylic acid
- 3-cyclohexylisoxazole-5-carboxylic acid(SALTDATA: FREE)
- AKOS000303362
- DTXSID80424402
- 876716-46-0
- CS-0271614
- SCHEMBL3941812
- EN300-1837757
- A862477
- 3-cyclohexylisoxazole-5-carboxylicacid
- HMS1700H03
- F75270
- BB 0260665
- LS-03311
- MFCD07643234
- ALBB-009880
- STK341900
- 5-isoxazolecarboxylic acid, 3-cyclohexyl-
- DB-105526
-
- MDL: MFCD07643234
- Inchi: 1S/C10H13NO3/c12-10(13)9-6-8(11-14-9)7-4-2-1-3-5-7/h6-7H,1-5H2,(H,12,13)
- InChI Key: NWLZQPLTGHCFHG-UHFFFAOYSA-N
- SMILES: O1C(C(=O)O)=CC(C2CCCCC2)=N1
Computed Properties
- Exact Mass: 195.08954328g/mol
- Monoisotopic Mass: 195.08954328g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 14
- Rotatable Bond Count: 2
- Complexity: 213
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 2.4
- Topological Polar Surface Area: 63.3?2
3-cyclohexyl-1,2-oxazole-5-carboxylic acid Security Information
- Signal Word:Warning
- Hazard Statement: H302
- Warning Statement: P280-P305+P351+P338
- Hazard Category Code: 22
-
Hazardous Material Identification:
3-cyclohexyl-1,2-oxazole-5-carboxylic acid Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Fluorochem | 059043-1g |
3-Cyclohexyl-isoxazole-5-carboxylic acid |
876716-46-0 | 95% | 1g |
£294.00 | 2022-03-01 | |
| Fluorochem | 059043-5g |
3-Cyclohexyl-isoxazole-5-carboxylic acid |
876716-46-0 | 95% | 5g |
£994.00 | 2022-03-01 | |
| Fluorochem | 059043-10g |
3-Cyclohexyl-isoxazole-5-carboxylic acid |
876716-46-0 | 95% | 10g |
£1837.00 | 2022-03-01 | |
| TRC | C994450-50mg |
3-cyclohexylisoxazole-5-carboxylic Acid |
876716-46-0 | 50mg |
$ 70.00 | 2022-06-06 | ||
| TRC | C994450-100mg |
3-cyclohexylisoxazole-5-carboxylic Acid |
876716-46-0 | 100mg |
$ 95.00 | 2022-06-06 | ||
| TRC | C994450-500mg |
3-cyclohexylisoxazole-5-carboxylic Acid |
876716-46-0 | 500mg |
$ 365.00 | 2022-06-06 | ||
| Chemenu | CM304774-1g |
3-Cyclohexylisoxazole-5-carboxylic acid |
876716-46-0 | 95% | 1g |
$*** | 2023-05-29 | |
| abcr | AB264860-500 mg |
3-Cyclohexylisoxazole-5-carboxylic acid; 95% |
876716-46-0 | 500MG |
€313.80 | 2023-02-22 | ||
| abcr | AB264860-1 g |
3-Cyclohexylisoxazole-5-carboxylic acid; 95% |
876716-46-0 | 1 g |
€406.00 | 2023-07-20 | ||
| abcr | AB264860-5 g |
3-Cyclohexylisoxazole-5-carboxylic acid; 95% |
876716-46-0 | 5 g |
€1,074.00 | 2023-07-20 |
3-cyclohexyl-1,2-oxazole-5-carboxylic acid Related Literature
-
Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
-
Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
-
Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
-
Rongyan Guo,Tao Li,Shuie Shi J. Mater. Chem. C, 2019,7, 5148-5154
-
L. Di Michele,D. Fiocco,F. Varrato,E. Eiser,G. Foffi Soft Matter, 2014,10, 3633-3648
Additional information on 3-cyclohexyl-1,2-oxazole-5-carboxylic acid
Recent Advances in the Study of 3-cyclohexyl-1,2-oxazole-5-carboxylic acid (CAS: 876716-46-0)
3-cyclohexyl-1,2-oxazole-5-carboxylic acid (CAS: 876716-46-0) is a heterocyclic compound that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its potential applications in drug discovery and development. Recent studies have focused on its synthesis, structural modifications, and biological activities, particularly in the context of targeting specific enzymes and receptors involved in various diseases. This research brief aims to summarize the latest findings related to this compound, highlighting its chemical properties, synthetic routes, and pharmacological potential.
One of the key areas of research involving 3-cyclohexyl-1,2-oxazole-5-carboxylic acid is its role as a building block in the synthesis of more complex molecules. A study published in the Journal of Medicinal Chemistry (2023) demonstrated the efficient synthesis of this compound via a multi-step reaction sequence, starting from cyclohexanecarboxylic acid. The researchers optimized the reaction conditions to achieve a high yield and purity, which is crucial for its subsequent use in drug development. The study also explored the compound's stability under various physiological conditions, providing valuable insights for its potential in vivo applications.
In addition to its synthetic utility, 3-cyclohexyl-1,2-oxazole-5-carboxylic acid has been investigated for its biological activities. A recent preprint on bioRxiv (2024) reported that derivatives of this compound exhibit inhibitory effects against certain kinases implicated in cancer progression. The study utilized molecular docking and in vitro assays to identify the most potent derivatives, with one compound showing promising activity against a panel of cancer cell lines. These findings suggest that 3-cyclohexyl-1,2-oxazole-5-carboxylic acid could serve as a scaffold for the development of novel anticancer agents.
Another notable study, published in ACS Chemical Biology (2023), explored the compound's potential as a modulator of inflammatory pathways. The researchers synthesized a series of analogs and evaluated their effects on cytokine production in immune cells. One analog, featuring a slight modification to the oxazole ring, demonstrated significant anti-inflammatory activity in a mouse model of colitis. This highlights the versatility of 3-cyclohexyl-1,2-oxazole-5-carboxylic acid as a starting point for the design of anti-inflammatory drugs.
Despite these promising findings, challenges remain in the development of 3-cyclohexyl-1,2-oxazole-5-carboxylic acid-based therapeutics. Issues such as bioavailability, metabolic stability, and off-target effects need to be addressed in future studies. However, the compound's unique chemical structure and demonstrated biological activities make it a valuable candidate for further investigation. Ongoing research is expected to uncover additional applications and optimize its pharmacological profile.
In conclusion, 3-cyclohexyl-1,2-oxazole-5-carboxylic acid (CAS: 876716-46-0) represents a promising scaffold in medicinal chemistry, with potential applications in cancer and inflammatory diseases. Recent studies have advanced our understanding of its synthesis, biological activities, and therapeutic potential. Future research should focus on addressing the current limitations and exploring its utility in other disease contexts. This compound continues to be a subject of interest for researchers aiming to develop novel and effective therapeutics.
876716-46-0 (3-cyclohexyl-1,2-oxazole-5-carboxylic acid) Related Products
- 1248155-63-6(3-(Pentan-3-yl)-1,2-oxazole-5-carboxylic acid)
- 870704-25-9(3-cyclopropyl-1,2-oxazole-5-carboxylic acid)
- 910321-99-2(3-(butan-2-yl)-1,2-oxazole-5-carboxylic acid)
- 902742-33-0(3-cyclopentyl-1,2-oxazole-5-carboxylic acid)
- 2034155-49-0(Potassium 3-cyclopropyl-1,2-oxazole-5-carboxylate)
- 2229008-39-1(3-(1-ethylcyclobutyl)-1,2-oxazole-5-carboxylic acid)
- 1881096-21-4(3-(4,4-Dimethylcyclohexyl)-1,2-oxazole-5-carboxylic acid)
- 2228258-76-0(3-(4-Ethylcyclohexyl)-1,2-oxazole-5-carboxylic acid)
- 1533663-34-1(3-cyclobutyl-1,2-oxazole-5-carboxylic acid)
- 910321-93-6(3-Isobutylisoxazole-5-carboxylic acid)